88 related articles for article (PubMed ID: 28035349)
1. Monoclonal antibodies targeting non-small cell lung cancer stem-like cells by multipotent cancer stem cell monoclonal antibody library.
Cao K; Pan Y; Yu L; Shu X; Yang J; Sun L; Sun L; Yang Z; Ran Y
Int J Oncol; 2017 Feb; 50(2):587-596. PubMed ID: 28035349
[TBL] [Abstract][Full Text] [Related]
2. Casticin suppresses self-renewal and invasion of lung cancer stem-like cells from A549 cells through down-regulation of pAkt.
Liu F; Cao X; Liu Z; Guo H; Ren K; Quan M; Zhou Y; Xiang H; Cao J
Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):15-21. PubMed ID: 24247269
[TBL] [Abstract][Full Text] [Related]
3. GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway.
Lu C; Huang T; Chen W; Lu H
Oncol Rep; 2015 Jul; 34(1):244-50. PubMed ID: 25955300
[TBL] [Abstract][Full Text] [Related]
4. A candidate Chinese medicine preparation-Fructus Viticis Total Flavonoids inhibits stem-like characteristics of lung cancer stem-like cells.
Cao X; Zou H; Cao J; Cui Y; Sun S; Ren K; Song Z; Li D; Quan M
BMC Complement Altern Med; 2016 Sep; 16():364. PubMed ID: 27633248
[TBL] [Abstract][Full Text] [Related]
5. Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway.
Shu X; Cao KY; Liu HQ; Yu L; Sun LX; Yang ZH; Wu CA; Ran YL
Stem Cell Res Ther; 2021 Feb; 12(1):119. PubMed ID: 33579362
[TBL] [Abstract][Full Text] [Related]
6. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
7. Isovitexin Suppresses Stemness of Lung Cancer Stem-Like Cells through Blockage of MnSOD/CaMKII/AMPK Signaling and Glycolysis Inhibition.
Liu F; Yuan Q; Cao X; Zhang J; Cao J; Zhang J; Xia L
Biomed Res Int; 2021; 2021():9972057. PubMed ID: 34195288
[TBL] [Abstract][Full Text] [Related]
8. Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line.
Zhao C; Setrerrahmane S; Xu H
Oncol Rep; 2015 Oct; 34(4):2126-32. PubMed ID: 26239272
[TBL] [Abstract][Full Text] [Related]
9. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S
Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment.
Kuo WY; Wu CY; Hwu L; Lee JS; Tsai CH; Lin KP; Wang HE; Chou TY; Tsai CM; Gelovani J; Liu RS
Oncotarget; 2015 Apr; 6(11):8663-75. PubMed ID: 25796627
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of liver cancer in vitro and in mice by monoclonal antibody targeting epithelial specific antigen-positive liver cancer stem cells in combination with cisplatin].
He YY; Yu L; Rong Y; Sun LX; Sun LC; Yang ZH; Ran YL; Li L
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):333-9. PubMed ID: 27188604
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer.
Feng L; Yao HP; Zhou YQ; Zhou J; Zhang R; Wang MH
J Exp Clin Cancer Res; 2016 Apr; 35():70. PubMed ID: 27102688
[TBL] [Abstract][Full Text] [Related]
13. Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer.
Sun L; Chen L; Sun L; Pan J; Yu L; Han L; Yang Z; Luo Y; Ran Y
Mol Cell Proteomics; 2013 Feb; 12(2):395-406. PubMed ID: 23184915
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
[TBL] [Abstract][Full Text] [Related]
15. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
[TBL] [Abstract][Full Text] [Related]
18. Puerarin 6″-O-xyloside suppresses growth, self-renewal and invasion of lung cancer stem-like cells derived from A549 cells via regulating Akt/c-Myc signalling.
Tao X; Yin Y; Lian D; Gu H; Chen W; Yang L; Yin G; Liu P; Li L; Wei Y; Xie Z; Liu F; Sui H; Yan D; Tao W
Clin Exp Pharmacol Physiol; 2020 Jul; 47(7):1311-1319. PubMed ID: 32124474
[TBL] [Abstract][Full Text] [Related]
19. shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells.
Xu Y; Hu YD; Zhou J; Zhang MH; Yuan WW; Luo Y
Oncol Rep; 2012 Aug; 28(2):629-39. PubMed ID: 22664532
[TBL] [Abstract][Full Text] [Related]
20. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.
de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A
Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]